Invention Grant
- Patent Title: Deuterated CFTR potentiators
-
Application No.: US15762264Application Date: 2016-09-23
-
Publication No.: US10759721B2Publication Date: 2020-09-01
- Inventor: Adam J. Morgan , Roger D. Tung
- Applicant: Vertex Pharmaceuticals (Europe) Limited
- Applicant Address: GB London
- Assignee: Vertex Pharmaceuticals (Europe) Limited
- Current Assignee: Vertex Pharmaceuticals (Europe) Limited
- Current Assignee Address: GB London
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP.
- International Application: PCT/US2016/053323 WO 20160923
- International Announcement: WO2017/053711 WO 20170330
- Main IPC: C07B49/00
- IPC: C07B49/00 ; C07D215/56
Abstract:
This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein each X and each R is defined within. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
Public/Granted literature
- US20200031776A1 DEUTERATED CFTR POTENTIATORS Public/Granted day:2020-01-30
Information query
